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eregulation of cyclin E expression has been associated
with a broad spectrum of human malignancies.
Analysis of DNA replication in cells constitutively
expressing cyclin E at levels similar to those observed in a
subset of tumor-derived cell lines indicates that initiation of
replication and possibly fork movement are severely impaired.
Such cells show a speciﬁc defect in loading of initiator
proteins Mcm4, Mcm7, and to a lesser degree, Mcm2 onto
chromatin during telophase and early G1 when Mcm2–7
are normally recruited to license origins of replication.
D
 
Because minichromosome maintenance complex proteins
are thought to function as a heterohexamer, loading of
Mcm2-, Mcm4-, and Mcm7-depleted complexes is likely to
underlie the S phase defects observed in cyclin E–deregulated
cells, consistent with a role for minichromosome maintenance
complex proteins in initiation of replication and fork move-
ment. Cyclin E–mediated impairment of DNA replication
provides a potential mechanism for chromosome instability
observed as a consequence of cyclin E deregulation.
 
Introduction
 
Cyclin E, a positive regulatory subunit of Cdk2, normally
accumulates periodically at the G1/S transition, where it
promotes entry into S phase and other DNA replication–
associated functions (Sauer and Lehner, 1995; Ekholm and
Reed, 2000). In somatic mammalian cells, cyclin E levels
specifically decline during S phase, reaching low or unde-
tectable levels by the time replication is complete (Ekholm et
al., 2001). However, in many types of human cancer cyclin
E is overexpressed, and in some cases its expression becomes
deregulated relative to the cell cycle (Keyomarsi et al., 1995;
Sandhu and Slingerland, 2000; Erlanson and Landberg,
2001; Erlandsson et al., 2003; Schraml et al., 2003; Reed et
al., 2004). That cyclin E deregulation is directly implicated
in the etiology of cancer is supported by at least two lines of
evidence. First, mice carrying a transgene programmed to
express cyclin E at an elevated level and without cell cycle
regulation in the mammary epithelium during pregnancy
and lactation develop mammary adenocarcinomas (Bortner
and Rosenberg, 1997). Second, the gene encoding hCdc4, a
protein required for turnover of cyclin E during S phase, is
found to be mutated and to have undergone allelic loss in
several types of cancer, leading to cyclin E deregulation
(Moberg et al., 2001; Strohmaier et al., 2001; Spruck et al.,
2002; Rajagopalan et al., 2004). In the latter case, 
 
hCDC4
 
mutation and concomitant cyclin E deregulation correlate
with higher tumor grade, more advanced stage, and metasta-
sis, compared with tumors without cyclin E deregulation
(Spruck et al., 2002). Together, these observations suggest
that deregulation of cyclin E is a functionally significant factor
in the development and progression of malignant disease.
Although it is not yet known how cyclin E deregulation
promotes tumorigenesis, one possible mechanism may be
through the generation of aneuploidy (Duesberg and Li,
2003; Fabarius et al., 2003). Deregulation of cyclin E ex-
pression in nontransformed rodent fibroblasts and human
mammary epithelial cells caused elevated frequencies of
chromosome losses and gains, as well as polyploidy (Spruck et
al., 1999; Loeb and Loeb, 2000). Therefore, cyclin E–mediated
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genomic instability may constitute a functional link to ma-
lignancy, although this remains to be demonstrated in an in
vivo model.
The generation of aneuploid cells can come about through
a variety of mechanisms ranging from DNA damage that is
not correctly repaired to defects in chromosome segregation
during mitosis (Loeb and Loeb, 2000; Jallepalli and Len-
gauer, 2001; Masuda and Takahashi, 2002). Of potential
significance is the paradoxical observation that deregulated
cyclin E expression accelerates the G1/S transition (Ohtsubo
and Roberts, 1993; Resnitzky et al., 1994; Wimmel et al.,
1994), yet leads to a slowing of S phase (Ohtsubo and Rob-
erts, 1993; Resnitzky et al., 1994; Spruck et al., 1999). In
principle, impairment of DNA replication could elevate the
frequency of cells with incompletely replicated chromo-
somes undergoing mitosis. The inevitable result of such reg-
ulatory accidents would most likely be chromatid nondis-
junction and subsequent aneuploidy.
The apparent paradox of cyclin E deregulation on the
one hand accelerating the rate of entry of cells into S
phase, but on the other causing inefficient progression
through S phase can be resolved if one considers the role(s)
of Cdks in regulating DNA replication. Cdk activity is
clearly required for initiating DNA replication (Lei and
Tye, 2001; Nishitani and Lygerou, 2002; Woo and Poon,
2003), and it is likely that cyclin E–Cdk2 has a role in this
context, consistent with deregulated expression of cyclin E
accelerating the G1/S transition. At the same time, investi-
gation of the requirements for assembly of prereplication
complexes (preRCs) in yeast and 
 
Xenopus
 
 egg-based in
vitro DNA replication systems has indicated that Cdk ac-
tivities must be reduced to low levels or eliminated for this
process to occur (Lei and Tye, 2001; Nishitani and Ly-
gerou, 2002; Woo and Poon, 2003). PreRCs are formed
by the six-subunit origin recognition complex (ORC) as
well as initiation factors Cdc6, Cdt1, Mcm2–7, and possi-
bly other proteins (Lei and Tye, 2001; Nishitani and
Lygerou, 2002). Therefore, the negative effect of cyclin E
deregulation on DNA replication could be a consequence
of inappropriate Cdk activity at the time when preRC
complexes are normally assembled—the end of mitosis
and the beginning of G1. To clearly define the link be-
tween cyclin E deregulation and replication impairment,
an analysis of preRC assembly was performed in human
cells ectopically expressing high levels of cyclin E via ade-
noviral transduction. In this paper, we show that deregula-
tion of cyclin E expression does indeed interfere with
preRC assembly, leading to defects in replication initiation
and possibly in fork movement.
 
Results
 
Deregulation of cyclin E expression accelerates 
S phase entry
 
To study the effect of constitutive cyclin E expression on
DNA replication in mammalian cells, KB cells were trans-
duced with a recombinant adenovirus containing a cDNA
encoding human cyclin E (E-Ad; see Materials and meth-
ods). At an multiplicity of infection of 100 almost all cells
were shown to be positive for cyclin E immunofluorescence
staining, whereas in cells transduced with a control adeno-
virus (c-Ad) only 50% of the cells were found to be positive
for cyclin E immunofluorescence staining, a level also found
in nontransduced cells (unpublished data).
It has been shown previously that premature expression of
cyclin E results in shortening of the G1 phase and acceler-
ated S phase entry (Ohtsubo and Roberts, 1993; Resnitzky
et al., 1994; Wimmel et al., 1994). To confirm that acute
cyclin E expression obtained by adenoviral transduction af-
fects the duration of G1 phase and timing of entry into S
phase, KB cells, chosen for their high efficiency of adenoviral
transduction, were transduced with E-Ad or c-Ad. Trans-
duced cells were then synchronized by mitotic shake-off,
plated onto glass slides in the presence of BrdU, and ana-
lyzed by immunofluorescence microscopy for BrdU staining
at different times after mitosis. As can be seen in Fig. 1 a,
cells transduced with E-Ad entered S phase synchronously
between 4 and 10 h after exiting mitosis, with 50% of the
cells scoring positive for BrdU 5 h after mitosis. In control
cells, entry into S phase began later with more heteroge-
neous kinetics. Not until 8 h after mitosis did 50% of the
population score positive for BrdU. These results are in
agreement with previous reports showing that constitutive
expression of cyclin E accelerates S phase entry (Ohtsubo
and Roberts, 1993; Resnitzky et al., 1994; Wimmel et al.,
1994) and that cells enter S phase at a relatively fixed inter-
val after the accumulation of cyclin E (Ekholm et al., 2001),
accounting for the more synchronous entry into S phase of
the E-Ad–transduced population.
 
Deregulation of cyclin E impairs DNA replication
 
Deregulated expression of cyclin E has also been inferred to
result in slowing of S phase progression (Ohtsubo and Rob-
erts, 1993; Resnitzky et al., 1994; Spruck et al., 1999), al-
though no direct analysis of DNA synthetic rate or of dose
responsiveness to cyclin E levels was reported. Therefore,
two-dimensional flow cytometric analysis of cells transduced
with E-Ad and c-Ad and then subjected to a short pulse of
BrdU incorporation was performed to investigate the effect
of deregulated cyclin E expression on DNA replication. As
shown in Fig. 1 b, 24 h after transduction 48% of cells
transduced with E-Ad were in S phase, whereas only 35% of
cells transduced with c-Ad were in S phase. Furthermore,
this effect was shown to be dose dependent, as the percent-
age of cells in S phase was found to increase with increasing
multiplicity of infection (Fig. 1 b).
To determine whether deregulated expression of cyclin E
affects the efficiency of DNA replication, individual pulse-
labeled cells with an early S phase BrdU staining pattern
(Nakamura et al., 1986; Nakayasu and Berezney, 1989)
were compared from the E-Ad– and c-Ad–transduced popu-
lations after analysis by immunofluorescence deconvolution
microscopy. Compared with control cells, cells with deregu-
lated cyclin E expression contained a reduced number of
BrdU foci, and these foci exhibited a significantly lower
fluorescence intensity (Fig. 1 c). Although the exact nature
of such BrdU foci is not known, presumably they corre-
spond to clusters of newly replicated DNA strands. There-
fore, these data are consistent with the notion that deregula-
tion of cyclin E results in a reduced rate of DNA synthesis. 
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This provides a mechanistic basis for the accumulation of S
phase cells observed by flow cytometric analysis (Fig. 1 b).
 
Initiation or elongation?
 
The observed reduction of both the number and staining in-
tensity of BrdU foci in cells with constitutive cyclin E ex-
pression (Fig. 1 c) indicates a reduced rate of replication, but
doesn’t distinguish between impairment of initiation or im-
pairment of fork progression. Therefore, we analyzed the lo-
calization patterns of BrdU and proliferating cell nuclear an-
tigen (PCNA) in individual early S phase cells with or
without constitutive cyclin E expression. As a processivity
factor for DNA polymerase 
 
 
 
 during replication (Prelich et
al., 1987; Krishna et al., 1994; Fukuda et al., 1995; Kelman,
1997), PCNA has been shown to be localized at the replica-
tion fork and to colocalize with newly synthesized DNA la-
beled with BrdU (Hozak et al., 1993; Takanari et al., 1994;
Somanathan et al., 2001). Therefore, we used PCNA as a
quantitative marker for replication forks. Presumably, the
greater the intensity of PCNA staining, the greater the num-
ber of replication forks assembled. In early S phase, the
number of replication forks should be roughly proportional
to the number of origins used. As can be seen in Fig. 2, early
S phase cells transduced with E-Ad exhibit reduced BrdU
staining as well as reduced PCNA staining. For PCNA, there
was a reduction in the number of foci and of staining inten-
sity of individual foci (Fig. 2), as observed for BrdU (Fig. 1 c
and Fig. 2). These results suggest that deregulation of cyclin
E expression results in a reduction in the number of origins
used in early S phase, consistent with a defect in replication
initiation. Interestingly, however, in the E-Ad–transduced
population many nuclei were observed in which PCNA foci
did not correspond to BrdU foci, compared with nuclei in
the c-Ad–transduced population. Such a pattern is consis-
tent with inactive or stalled replication forks. Thus, deregu-
lation of cyclin E expression may also impair replication fork
movement.
Before proceeding further in this investigation, we con-
firmed that cyclin E levels under viral transduction condi-
tions were comparable to those in tumors with deregulated
cyclin E. Therefore, we compared both cyclin E protein lev-
els and associated Cdk2 kinase activity in E-Ad–transduced
KB cells to those in selected breast cancer–derived cell lines
and found them to fall within an equivalent range (Fig. 3 a).
Figure 1. Cell cycle effects on deregulation of cyclin E expression. (a) Time course of S phase entry of cyclin E–deregulated and control cells. 
Cells transduced with cyclin E recombinant adenovirus (E-Ad) and control adenovirus (c-Ad) were synchronized by mitotic shake-off and 
replated into medium containing BrdU. S phase entry was scored by immunofluorescence microscopy using anti-BrdU antibodies. The experiment 
was performed in triplicate and error bars represent 1 SD. (b) Flow cytometric cell cycle analysis of cyclin E–deregulated and control cells. 
Asynchronous cells transduced with c-Ad or E-Ad were subjected to a 15-min BrdU pulse before fixation and preparation for flow cytometric 
analysis. Abscissa indicates nuclear DNA content based on propidium iodide staining; ordinate indicates BrdU incorporation based on 
immunofluorescence. (c) Replication foci in early S phase cells with deregulated cyclin E. E-Ad– and c-Ad–transduced cells, respectively, 
were subjected to a 15-min BrdU pulse and labeled DNA was analyzed by immunofluorescence. Two representative early S phase cells from 
each population are shown. DAPI-stained DNA is shown in blue; incorporated BrdU is shown in green. 
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A potentially trivial explanation for impairment of DNA
replication in E-Ad–transduced cells is competition with cy-
clin A for a limiting pool of the catalytic subunit Cdk2. Cy-
clin A–Cdk2 has been shown to be required for progression
through S phase. Therefore, Cdk2 was immunoprecipitated
from extracts prepared from E-Ad– and c-Ad–transduced S
phase cells and was analyzed for cyclin A binding by immu-
noblotting. Although there is significantly more cyclin E in
S phase extracts prepared from E-Ad–transduced cells, the
amount of cyclin A bound to Cdk2 is comparable in the two
extracts (Fig. 3 b). Therefore, S phase effects of cyclin E de-
regulation under the conditions used in this paper cannot be
attributed to competition with cyclin A.
 
Altered chromatin loading of MCM proteins in cells 
constitutively expressing cyclin E
 
Previous reports in yeast and 
 
Xenopus
 
 egg extracts have shown
that Cdk activity must be reduced to low levels to allow as-
sembly of preRCs, a criterion that is normally met during late
mitosis and early G1 phase in mammalian somatic cells (Yan
and Newport, 1995; Coverley et al., 1996; Wuarin and
Nurse, 1996; Hua et al., 1997; Nishitani and Lygerou,
2002). To determine whether constitutive cyclin E expres-
sion in late mitosis and early G1 impairs preRC assembly, we
studied chromatin loading of various preRC components in
telophase cells, with or without constitutive cyclin E expres-
sion. First it was confirmed that in E-Ad–transduced cells,
cyclin E was expressed at the time when preRCs are normally
assembled. After adenovirus transduction, cells were synchro-
nized by mitotic shake-off and were analyzed for cyclin E ex-
pression by immunofluorescence deconvolution microscopy
at 
 
 
 
1 h after mitosis. In the control population cyclin E was
not detected in any telophase cells. However, for the E-Ad–
transduced population, most telophase cells were cyclin E
positive (Fig. 3 c). For comparison, telophase SUM149PT
cells processed in parallel are shown (Fig. 3 c). SUM149PT is
a breast cancer–derived cell line mutated for 
 
hCDC4/FBW7
 
encoding a critical specificity factor required for cyclin E
turnover (Strohmaier et al., 2001). As can be seen, the typical
level of cyclin E in telophase E-Ad–transduced cells is compa-
rable to that in a nontransduced tumor-derived cell line de-
regulated for cyclin E expression as a result of mutation.
The association of preRC components with chromatin
during telophase was first determined by immunofluores-
Figure 2. Titration of replication forks by PCNA 
staining in early S phase nuclei with deregulated 
cyclin E. c-Ad– and E-Ad–transduced cells 
were subjected to a 15-min BrdU pulse and 
were analyzed simultaneously for BrdU incor-
poration and chromatin-bound PCNA by 
immunofluorescence deconvolution microscopy. 
(a) Images of representative early S phase cells 
are shown. Red, PCNA; green, BrdU; blue, 
DNA (DAPI). (b) Histograms representing aver-
age values of integrated intensities (in arbitrary 
units) of nuclear staining shown in panel a. 
Error bars are equivalent to 1 SD. 
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cence microscopy of cells that were subjected to a short de-
tergent extraction to remove proteins not tightly bound to
chromatin (see Materials and methods). Constitutive cyclin
E expression was found to dramatically reduce chromatin
loading of Mcm4 in telophase cells compared with control
cells (Fig. 4 b). However, the total level of Mcm4 protein
was not altered because nondetergent-extracted cells showed
no difference in the Mcm4 staining pattern (Fig. 4 a). For
Mcm3 and Mcm7 there was a lesser but significant decrease
in chromatin loading in telophase cells with deregulated cy-
clin E expression (Fig. 5). For Mcm2 and Mcm6 no signifi-
cant decrease was observed (Fig. S1, available at http://
www.jcb.org/cgi/content/full/jcb.200404092/DC1).
The presence of initiator proteins on chromatin was also
analyzed in cells transduced with c-Ad or E-Ad by immuno-
blotting after biochemical fractionation (Fig. 6 a; Méndez
and Stillman, 2000). The chromatin localization of compo-
nents of the human ORC (Orc1, Orc2) or initiator protein
Cdc6 was not affected by constitutive expression of cyclin E
(Fig. 6 b). However, a strong impairment of chromatin
loading was noticed for both Mcm4 and Mcm7, with much
more modest effects observed for the other four minichro-
mosome maintenance complex (MCM) proteins (Fig. 6 b).
 
Kinetics of MCM protein loading after mitotic exit
 
Experiments described above document a cyclin E–medi-
ated impairment of Mcm4 and Mcm7 loading, and to a
lesser degree, loading of other MCM subunits onto chroma-
tin during telophase. To determine whether a deficiency of
Mcm4 and Mcm7 (as well as other subunits) persists into
G1 and early S phase, two experiments were performed.
First, c-Ad– or E-Ad–transduced cells were subjected to mi-
totic synchronization and shake-off. In this experiment, cells
were collected at prometaphase by treatment with nocoda-
zole after release from a double-thymidine block in order in-
crease the yield of mitotic cells. After shake-off in the pres-
ence of nocodazole, cells were replated in nocodazole-free
medium and harvested at intervals after mitosis, and MCM
protein binding to chromatin was determined by biochemi-
cal fractionation and immunoblotting. In control, c-Ad–
transduced cells, a significant fraction of Mcm4 was detected
on chromatin as early as 1 h after mitosis, as was seen in pre-
vious experiments without nocodazole (Fig. 4 b and Fig. 6
b). In contrast, very little Mcm4 was detected in the chro-
matin fraction in E-Ad–transduced cells (Fig. 7 a). At subse-
quent time points progressively more Mcm4 was loaded, al-
though the amount never reached parity with the control
population (Fig. 7 a). Loading of other MCM proteins is
shown numerically after quantitation of immunoblots and
normalization to the Orc2 signal, which is presumed to be
constant (Fig. 7 b). This experiment shows a significant im-
pairment of Mcm7 loading over the time course similar to
 
Figure 3.
 
Status of cyclin E and cyclin A in adenovirus-transduced 
cells.
 
 (a) Levels of cyclin E and cyclin E–Cdk2 kinase activity in 
cancer-derived cell lines. Protein extracts were prepared from 
c-Ad– and E-Ad–transduced KB cells as well as from four breast 
cancer–derived cell lines (SUM149-PT, MDA-MB-468, MDA-MB-436, 
and MDA-MB-157). The same extracts were used for SDS-PAGE 
followed by immunoblotting (top panels) and immunoprecipitation 
for histone H1 kinase assay (bottom panel). Quantitation of cyclin 
E–Cdk2 kinase activity (
 
32
 
P incorporation) is shown. (b) Cyclin E and 
cyclin A association with Cdk2 in S phase cyclin E–transduced cells. 
c-Ad– and E-Ad–transduced cells were synchronized in S phase by 
treatment with thymidine. Cell lysates were subjected to immuno-
precipitation using anti-Cdk2 antibody followed by SDS-PAGE 
and immunoblotting, or were analyzed directly by SDS-PAGE 
and immunoblotting. NI, nonimmune serum; WCE, whole-cell 
extract. Asterisk indicates principal isoform of endogenous cyclin E. 
(c) c-Ad– and E-Ad–transduced cells, as well as the SUM149PT 
breast cancer–derived cell line, were synchronized by thymidine block-
release; telophase cells were analyzed in parallel for cyclin E level by 
immunofluorescence deconvolution microscopy. Images of repre-
sentative telophase cells are shown. Red, cyclin E; blue, DNA (DAPI). 
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that of Mcm4 loading. In addition, there is an obvious im-
pairment of Mcm2 loading, but only at time points subse-
quent to 1 h after mitosis. Therefore, impairment of loading
of Mcm2, Mcm4, and Mcm7 are likely to contribute to the
S phase phenotypes associated with cyclin E deregulation.
To visualize the chromatin-bound Mcm4 levels during
early S phase, asynchronous cells were subjected to a short
BrdU pulse, and after detergent extraction were analyzed for
BrdU and Mcm4 by immunofluorescence deconvolution
microscopy. Early S phase cells selected based on the pattern
of BrdU foci were quantitated for Mcm4 signal (Fig. 7 c). A
comparison of the E-Ad–transduced and control popula-
tions indicated that even in early S phase, cells experiencing
deregulated cyclin E expression had a deficiency in Mcm4
bound to chromatin, although this deficiency was not quan-
titatively as great as in telophase (Fig. 7 c). To confirm that a
partial reduction in Mcm4 chromatin loading could have a
significant impact on DNA replication, RNA interference
was used to reduce the total intracellular level of Mcm4, and
asynchronous cells were given a 15-min pulse of BrdU to
mark S phase cells. Microscopic analysis of detergent-ex-
tracted early S phase cells and biochemical analysis of chro-
matin indicated that partial reduction of chromatin-bound
Mcm4 correlated with a significant reduction in BrdU in-
corporation (Fig. 8). Thus, Mcm4 loading is rate-limiting
for DNA replication.
 
Altered chromatin loading of Mcm4 is dependent on 
Cdk2 activity
 
MCM proteins are normally phosphorylated and gradually
dissociate from chromatin as DNA replication proceeds
(Kubota et al., 1995; Todorov et al., 1995; Coue et al.,
1996; Fujita et al., 1996; Krude et al., 1996; Lei et al., 1996;
Holthoff et al., 1998; Méndez and Stillman, 2000). The ki-
nase activities responsible for this phosphorylation are be-
lieved to be Dbf4/cdc7 and cyclin A–Cdk2 (for review see
Lei and Tye, 2001). To investigate the possibility that dereg-
ulated cyclin E–Cdk2 activity might phosphorylate Mcm4
and thereby prevent its binding to chromatin during telo-
phase, a Cdk2 inhibitor, roscovitine, was added to the me-
dium when cells were replated after mitotic shake-off. As can
be seen in Fig. 4 b, Mcm4 chromatin loading in telophase
was restored when cells with constitutive cyclin E levels were
treated with roscovitine as they proceeded through mitosis,
confirming that the observed reduction of Mcm4 chromatin
binding when cyclin E is deregulated is dependent on Cdk2
kinase activity. However, this experiment does not distin-
guish between a direct effect mediated by phosphorylation of
Mcm4 or an indirect effect mediated by phosphorylation of
other proteins. It is noteworthy that under appropriate SDS-
PAGE separation conditions, hyperphosphorylated Mcm4
could be detected in the nonchromatin-bound fraction of
telophase cells experiencing deregulated cyclin E expression
(Fig. 9 a). Treatment of the soluble nuclear fractions with al-
kaline phosphatase eliminated the slowest migrating isoform
(Fig. 9 b, lanes 2 and 6). Interestingly, the chromatin-bound
fraction of Mcm4 was not hyperphosphorylated (Fig. 9 a,
c-Ad P3; Fig. 9 b, lane 4). However, this experiment does
not prove that hyperphosphorylation of Mcm4 under these
conditions is mediated by cyclin E–Cdk2.
 
Discussion
 
Cyclin E deregulation, aneuploidy, and cancer
 
Cyclin E is found elevated in many types of tumors, often
correlated with aggressive disease and poor prognosis (Keyo-
Figure 4. Analysis of chromatin-bound Mcm4 in 
telophase cells with deregulated cyclin E. c-Ad– 
and E-Ad–transduced cells were synchronized by 
mitotic shake-off. At 1 h after mitosis, cells were 
either (a) directly fixed and analyzed for Mcm4 by 
immunofluorescence deconvolution microscopy 
or (b) subjected to mild detergent extraction before 
fixation and then analyzed for Mcm4 by immuno-
fluorescence deconvolution microscopy. In parallel, 
E-Ad–transduced cells were incubated with the 
Cdk2 inhibitor roscovitine subsequent to mitotic 
shake-off. Images of representative telophase cells 
are shown for each population. Mcm4 is shown in 
red; DAPI staining of DNA is shown in blue. 
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marsi et al., 1995; Nielsen et al., 1997, 1998, 1999; Sandhu
and Slingerland, 2000; Donnellan et al., 2001; Erlanson and
Landberg, 2001; Schraml et al., 2003). However, it is not
simple overexpression of cyclin E, but the loss of its cell cycle
regulation that might be linked to cancer (Erlandsson et al.,
2003; Reed et al., 2004). A recent analysis of endometrial
carcinomas revealed that mutation of 
 
hCDC4
 
, a gene crucial
for cell cycle regulation of cyclin E degradation, did not cor-
relate well with elevated levels of cyclin E (Spruck et al.,
2002; Reed et al., 2004). However, 
 
hCDC4
 
 mutation corre-
lated extremely well with deregulation of cyclin E relative to
the cell cycle.
In an in vitro tissue culture model, deregulation of cyclin E
expression was found to promote chromosome instability
(Spruck et al., 1999). Accordingly, several hypotheses can be
considered to explain how the negative impact of cyclin E de-
regulation on DNA replication could result in chromosome
instability. First, the interference with preRC assembly could
lead to a lower number of active replication origins, increasing
the average replicon size and resulting in higher frequencies of
stalled replication forks and double-stranded DNA breaks.
Second, the diminished rate of DNA replication could com-
Figure 5. Analysis of chromatin-bound Mcm3 and Mcm7 in 
telophase cells with deregulated cyclin E. c-Ad– and E-Ad–transduced 
cells were synchronized by mitotic shake-off. At 1 h after mitosis, cells 
were subjected to mild detergent extraction, fixed, and analyzed for 
(a) Mcm3 and (b) Mcm7 by immunofluorescence deconvolution 
microscopy. Images of representative telophase cells are shown. 
Red, Mcm3, Mcm7; blue, DNA (DAPI).
Figure 6. Chromatin loading of proteins associated with preRCs 
in cells with deregulated cyclin E. (a) c-Ad– and E-Ad–transduced 
cells were synchronized by mitotic shake-off. At 1 h after mitosis, 
cells were harvested and fractionated into a cytosolic supernatant 
(S2), a nuclear supernatant (S3), and a chromatin-enriched pellet 
(P3). (b) All fractions were separated by SDS-PAGE and were ana-
lyzed by Western blotting. Mek2 is used as a control for cytosolic 
localization, whereas Orc1 and Orc2 are controls for chromatin 
localization. Expression of cyclin E in the E-Ad–transduced pop-
ulation is also shown. 
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promise the processes of chromosome condensation and sister
chromatid cohesion because both these processes are coupled
to DNA synthesis at the replication fork. Third, slow DNA
replication could lead to incompletely replicated chromo-
somes at the time when cells would normally enter mitosis,
leading to nondisjunction events and ultimately karyotypic
anomalies. Eukaryotic cells possess checkpoint mechanisms to
prevent such catastrophes, but these presumably fail at a low
but finite frequency. Finally, deregulation of cyclin E may
directly compromise the normal intra-S phase checkpoint
mechanisms and consequently allow propagation of DNA
damage. These various scenarios are not mutually exclusive.
Figure 7. Effects of deregulated cyclin E on chromatin association of MCM proteins as cells progress through G1 and in early S phase. 
c-Ad– and E-Ad–transduced cells were synchronized by nocodazole block and mitotic shake-off. At hourly intervals after mitosis, cells were 
harvested and fractionated as in Fig. 6. Western blotting of fractions separated by SDS-PAGE was performed with antibodies specific for Mcm2, 
Mcm3, Mcm4, Mcm5, Mcm6, Mcm7, Orc2, Mek2, and cyclin E. (a) Immunoblot of time course showing analysis of Mcm4, Orc2, Mek2, and 
cyclin E. (b) Quantitation of immunoblots of chromatin-bound fractions for MCM proteins relative to Orc2. The data are expressed as percentage 
of the maximal ratio observed during the time course. (c) c-Ad– and E-Ad–transduced cells were subjected to a 15-min BrdU pulse, and then 
were detergent extracted, fixed, and analyzed for BrdU incorporation and chromatin-bound Mcm4 by immunofluorescence microscopy. 
Typical early S phase cells were chosen based on BrdU focus pattern. Red, Mcm4; green, BrdU. 
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Cdk activity and DNA replication
 
Based on this and previous work, it is clear that Cdk activity
has an ambivalent relationship to DNA replication. On one
hand, it is activation of Cdks in late G1 that triggers the ini-
tiation of S phase. On the other, Cdk activity is antagonistic
to preRC assembly (Kelly and Brown, 2000; Lei and Tye,
2001; Nishitani and Lygerou, 2002; Woo and Poon, 2003).
These opposing regulatory modes are apparent in the para-
doxical effect of deregulated cyclin E on the cell cycle. Initia-
tion of S phase is advanced, consistent with cyclin E’s posi-
tive role in initiation. However, because all components of
the preRC are likely required for initiation of DNA replica-
tion, global replication proceeds much less efficiently as a re-
sult of cyclin E–Cdk2 impairment of preRC assembly. The
potential tension between Cdk-mediated activation and in-
hibition of replication is normally averted by imposing tight
temporal regulation on cyclin accumulation, thereby ex-
cluding cyclin–Cdk activity from the critical M phase/G1
boundary in virtually all cells. Deregulation of cyclin E ap-
parently defeats this highly conserved regulatory safeguard,
leading to genomic instability and ultimately malignancy.
Two recent works in yeast support the connection be-
tween Cdk deregulation, inefficient DNA replication, and
chromosome instability (Lengronne and Schwob, 2002;
Tanaka and Diffley, 2002). Deletion of the gene encoding a
Figure 8. Partial reduction of Mcm4 expression 
by RNA interference results in impairment of 
DNA replication. (a) HeLa cells were transfected 
with firefly luciferase siRNA (left) or with Mcm4 
siRNA (right), pulse labeled with BrdU, and 
analyzed by immunofluorescence microscopy 
after mild detergent extraction. Images of repre-
sentative early S phase cell are shown. Green, 
Mcm4; red, BrdU. (b) HeLa cells transfected 
with firefly luciferase siRNA and Mcm4 siRNA 
as in panel a were fractionated into soluble and 
chromatin-enriched fractions as described in 
Fig. 6. Total cell extracts (TCE) as well as sub-
cellular fractions were separated by SDS-PAGE 
and blots were probed with Mcm4 and Orc2 
antibodies, respectively. Orc2 serves as a loading 
control for the chromatin-enriched fraction.
Figure 9. Phosphorylation of Mcm4 in post-mitotic cells with 
deregulated cyclin E. (a) c-Ad– and E-Ad–transduced cells 1 h after 
mitosis were analyzed as described in Fig. 6 b, except that SDS-PAGE 
conditions were used that maximally separate phosphorylated 
Mcm4 species (10% acrylamide/bisacrylamide instead of 12.5%; 
longer run time). Orc2, Mek2, and Mcm4 are shown. (b) Aliquots 
of the S3 fractions shown in panel a were reanalyzed after treatment 
with alkaline phosphatase, in the absence or in the presence of 
an inhibitor. 
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Cdk1 inhibitor, Sic1, which results in inability to com-
pletely down-regulate Cdk activity in G1, impaired initia-
tion of DNA replication as was evidenced by high frequency
of mini-chromosome loss and an abnormally low density of
replication origins (Lengronne and Schwob, 2002). In an-
other paper, gross overexpression of yeast G1 cyclins, known
as Clns, also impaired replication, based on elevated rates of
plasmid loss (Tanaka and Diffley, 2002). In both cases,
there was evidence that the end result of Cdk deregula-
tion and/or overexpression was chromosomal rearrangements
that could be scored genetically. Moreover, it has been re-
cently reported that the number of active replication origins
influences the frequency of chromosomal rearrangements,
increasing it or reducing it in different mutant backgrounds
(Huang and Koshland, 2003). However, the relevance of
Sic1 loss and Cln overexpression to mammalian cells and
cancer must be considered cautiously because the regulation
of the G1/S phase transition by Cdks is quite different in
yeast compared with mammalian cells, as is the regulation of
preRC assembly. In yeast, Cdk activity prevents nuclear im-
port of MCM proteins and promotes degradation of Cdc6,
neither of which occurs in mammalian cells (Kimura et al.,
1994; Yan and Newport, 1995; Krude et al., 1996; Wuarin
and Nurse, 1996; Drury et al., 1997, 2000; Zachariae and
Nasmyth, 1999; Méndez and Stillman, 2000; Tanaka and
Diffley, 2002). Indeed, our data demonstrate that deregula-
tion of cyclin E does not affect the nuclear localization of
Mcm4, but does control its ability to load onto chromatin.
Futhermore, the level and loading efficiency of Cdc6 were
not affected.
A number of previous papers have analyzed the effects of
Cdk activities on association of MCM proteins with chroma-
tin. In 
 
Xenopus
 
 eggs and mammalian cells, high levels of both
cyclin A– and cyclin B–associated mitotic kinase activity have
been shown to reduce the affinity of MCM complexes for
chromatin and to promote release of MCM complexes pre-
sumably during late S phase, G2, and mitosis (Fujita et al.,
1996; Hendrickson et al., 1996; Findeisen et al., 1999).
Analysis of the specific effects of cyclin E on MCM loading
onto chromatin has largely been limited to 
 
Xenopus
 
 egg ex-
tracts. High cyclin E–Cdk2 activity was found to prevent
loading of MCM proteins, but could not dissociate them
once loaded (Hua et al., 1997; Findeisen et al., 1999). Inter-
estingly, MCM complexes are not a direct substrate of cyclin
E–Cdk2 in the 
 
Xenopus
 
 egg system (Findeisen et al., 1999).
However, it is not clear whether Cdk specificities observed
for MCM protein phosphorylation in 
 
Xenopus
 
 eggs are also
maintained in mammalian somatic cells.
 
The mechanics of MCM protein loading
 
In the current work, cyclin E–Cdk2 appears to impair the
loading specifically of Mcm2, Mcm4, and Mcm7 at telo-
phase and during G1. This is a surprising result because sta-
ble MCM complexes exist both in solution (Schwacha and
Bell, 2001) and on chromatin (Ritzi et al., 1998), and be-
cause MCM proteins assemble as complexes and subcom-
plexes (Maiorano et al., 2000) before being loaded onto
chromatin. On the other hand, we present data demonstrat-
ing that different individual MCM proteins load onto chro-
matin with distinct kinetic signatures even in the absence of
cyclin E deregulation. In particular, Mcm2 appears to load
at a later time than other MCM subunits. This finding may
indicate that MCM heteromeric complexes are assembled
subsequent to chromatin loading of individual subunits, or
that assembled MCM complexes as well as individual MCM
subunits can be loaded onto chromatin. If the latter is true,
the consequences of the coexistence of alternative loading
mechanisms for MCM protein function remain to be ex-
plored (Méndez and Stillman, 2003).
 
Materials and methods
 
Cell culture and synchronization
 
KB cells, derived from a human nasopharyngeal epidermoid carcinoma
and breast cancer–derived cell lines MDA-MB-157, -436, and -468 were
obtained from the American Type Culture Collection (Manassas, VA) and
were cultured as monolayers in DME (GIBCO BRL) supplemented with
10% FBS (GIBCO BRL), 100 U/ml penicillin, 0.1 mg/ml streptomycin, and
 
L
 
-glutamine (GIBCO BRL). Sum149PT, a breast cancer–derived cell line,
was obtained from the University of Michigan Breast Cell Tissue Bank
(Ann Arbor, MI) and was grown in medium recommended by the supplier.
All cells were grown at 37
 
 
 
C in 5% CO
 
2
 
.
For synchronization of cells in late M/early G1 phase by mitotic shake-
off, cells were first synchronized in early S phase by a triple-thymidine
block according to the following procedure: at 
 
 
 
30% confluence, 2 mM
thymidine was added to the medium and cells were incubated for 16 h be-
fore the thymidine-containing medium was removed. Cells were washed in
PBS and fresh medium was added. 10 h later, 2 mM thymidine was again
added to the medium. This procedure was repeated once more. During the
third thymidine block, cells were transduced with recombinant adenovirus
for 2 h in low volume (3 ml/162 cm
 
2
 
 flask). 14 h after the third thymidine
block, cells were released into fresh medium and progressed synchronously
in the cell cycle until they were collected by mitotic shake-off 10–12 h
later. Cells were detached by banging flasks on the bench 10 times, and mi-
totic cells were collected by pipetting off the medium and were then trans-
ferred to (a) 60-mm dishes containing a hematocytometer glass slide for im-
munofluorescence analysis; or (b) tissue culture flasks for cell fractionation/
immunoblotting analysis. In the time-course experiment where 80 ng/ml
nocodazole was used to maximize cell yield, it was added after release
from a second thymidine block, during which adenoviral transduction was
performed. When 
 
 
 
80% of the cells had rounded up, the shake-off proce-
dure described above was used and cells were transferred to tissue culture
flasks in medium without nocodazole for the designated incubation times.
 
Antibodies
 
pAbs against hMcm2 (CS732), hMcm6 (CS753), and hMcm7 (CS766) pro-
teins were raised in New Zealand White rabbits against synthetic short
peptides (corresponding to aa 131–150 in hMcm2, 9–26 in hMcm6, and
108–127 in hMcm7) conjugated to keyhole limpet hemocyanin. pAbs
against hMcm3 (CS738) and hMcm4 (CS739), and mAbs against hCdc6
have been described earlier (Méndez and Stillman, 2000). pAbs against
hOrc1 (CS769) and hOrc2 (CS205) have been described before (Gavin et
al., 1995; Méndez et al., 2002). mAb PC10 (anti-PCNA) has been de-
scribed previously (Waseem and Lane, 1990). Other primary antibodies
used in this paper are: mouse monoclonal anti-cyclin E (HE12; Dulic et al.,
1992), anti-Cdk2 (D12; Santa Cruz Biotechnology, Inc.), sheep polyclonal
anti-BrdU (Research Diagnostics, Inc.), and FITC-conjugated mouse mono-
clonal anti-BrdU (Becton Dickinson). Secondary antibodies Cy3-conju-
gated donkey anti–rabbit IgG, FITC-conjugated donkey anti–sheep IgG,
and Cy3-conjugated donkey anti–mouse IgG were purchased from Jackson
Immunoresearch Laboratories. HRP-conjugated anti–rabbit IgG and anti–
mouse IgG were obtained from Amersham Biosciences.
 
Recombinant adenovirus procedures
 
Recombinant adenovirus carrying the human cyclin E cDNA (E-Ad) was
provided by Jeffrey Albrecht (University of Minnesota, Minneapolis, MN).
c-Ad carried part of the 
 
 
 
-globin gene (John Cogswell and Susan Neill;
Glaxo-Wellcome, Research Triangle Park, NC). For transduction, KB cells
were incubated in a low volume (3 ml for a 162-cm
 
2
 
 tissue culture flask:
500 
 
 
 
l for a 3-cm dish) with the recombinant adenovirus diluted appropri-
ately in DME and 2% FBS for 2 h. After incubation in fresh medium con-
taining 10% FBS for an additional 24 h, cells were collected by mitotic
shake-off for analysis. 
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S phase entry assay
 
Cells were synchronized with a triple-thymidine block (see above), trans-
duced with recombinant adenovirus expressing the human cyclin E, col-
lected by mitotic shake-off, and replated in the presence of 10 
 
 
 
M BrdU.
At the indicated times, cells were harvested, fixed in 100% methanol for
1 h at RT, stained with FITC-conjugated anti-BrdU antiserum, and scored
for BrdU incorporation by immunofluorescence microscopy. 300 nuclei
were scored for BrdU incorporation for each time point.
 
Flow cytometry analysis
 
Before harvesting, virally transduced asynchronous cells were pulse la-
beled for 15 min with 10 
 
 
 
M BrdU. 10
 
6
 
 cells were resuspended in PBS,
fixed by adding 5 ml of 70% 
 
 
 
20
 
 
 
C ethanol drop-wise while vortexing,
and finally processed for propidium iodide and BrdU staining. Cells were
collected by centrifugation (for 5 min at 200 
 
g
 
) and treated with 1 ml of
2 N HCl 
 
 
 
 0.5% Triton X-100 for 30 min at RT to denature the DNA. The
cell suspension was neutralized by addition of 2 ml of 0.1 M Na
 
2
 
B
 
4
 
O
 
7
 
 (Bo-
rax). After collecting and washing the cells in PBS, the pellet was resus-
pended in 50 
 
 
 
l of 1
 
 
 
 PBS/1% BSA/0.5% Tween 20 to permeabilize cell
membranes and block nonspecific antibody binding. FITC-conjugated
anti-BrdU antibody was added to a final concentration of 2.5 
 
 
 
g/ml and
cells were incubated for 1 h at RT. After additional washing in 1
 
 
 
 PBS/1%
BSA/0.5% Tween 20, cells were collected, resuspended in 1 ml of 2 
 
 
 
g/ml
propidium iodide in PBS, and analyzed using a FACScan™ and CellQuest
software (Becton Dickinson).
 
Immunofluorescence and deconvolution microscopy
 
For immunostaining with anti-hMCM antibodies, cells were replated onto
glass coverslips. At the indicated times, cells were washed in PBS, treated
with 0.5% Triton X-100 in PBS for 1 min at RT to remove proteins not
tightly bound to chromatin (Todorov et al., 1995), and fixed in 4% PFA
(wt/vol) in PBS (pH 7.0) for 20 min at RT. After treatment with blocking
buffer (1% BSA and 0.5% Triton X-100 in PBS) for 15 min, the cells were
incubated with the indicated primary and secondary antibodies and were
further processed for immunofluorescence analysis as described previously
(Ekholm et al., 2001).
For Mcm4/BrdU double staining, cells were pulse labeled with 10 
 
 
 
M
BrdU for 15 min and processed as indicated above. After completion of
Mcm4 staining, cells were fixed again for 5 min at RT in 4% PFA in PBS (pH
7.0). The DNA was denatured by incubation in 2 N HCl at 37
 
 
 
C for 30 min.
After three washes in PBS and a 15-min incubation in blocking buffer, cells
were incubated with FITC-conjugated anti-BrdU antibody for 1 h at RT.
For PCNA/BrdU double staining, BrdU pulse-labeled cells were first
fixed in 2% PFA in PBS for 15 min at RT, and then in 100% methanol for
10 min at RT. Cells were treated with blocking buffer and incubated with
PC10 (anti-PCNA antibody) at 4
 
 
 
C overnight. Cy3-conjugated anti–mouse
IgG was used as secondary antibody. Cells were washed in TBS 
 
 
 
 0.02%
Tween 20 after every antibody incubation. To visualize BrdU, cells were
processed as described above.
Fluorescence data were collected using a DeltaVision
 
®
 
 wide-field opti-
cal sectioning microscope system (Applied Precision) based on an inverted
epifluorescence microscope (model IX-70; Olympus) as described previ-
ously (Reed et al., 2004).
 
Biochemical fractionation and immunoblot analysis
 
10
 
6
 
 cells, transduced with c-Ad or E-Ad and collected by mitotic shake-off
as indicated above, were subjected to the micro-fractionation protocol
originally described in Méndez and Stillman (2000) and schematized in
Fig. 6 A. To test the phosphorylation status of Mcm4 protein, 8-
 
 
 
l aliquots
of the soluble nuclear (S3) extracts from c-Ad– or E-Ad–transduced cells
were incubated in a total volume of 10 
 
 
 
l with 2 U calf intestinal alkaline
phosphatase (New England Biolabs, Inc.), either in the absence or in the
presence of 10 mM Na
 
2
 
VO
 
4
 
 as an inhibitor, for 30 min at 37
 
 
 
C.
Immunoblots were quantitated in a FluorChem™ 8000 digital imaging
system (Alpha Innotech, Inc.). hOrc2p, which is stably associated with the
chromatin during this window of the cell cycle, served as a loading control
for normalization. Data are presented as the percentage of the maximum
amount of each MCM species loaded onto chromatin during the experiment.
 
Immunoprecipitation and histone H1 kinase assay
 
Cell lysates were subjected to immunoprecipitation followed by histone
H1 kinase assay or Western blotting. In brief, 200 
 
 
 
g of the lysate was im-
munoprecipitated with 2 
 
 
 
l of the anti-cyclin E antibody HE172 or anti-
Cdk2 antibody for 1 h on ice. The precipitates were bound to G-Sepharose
beads (Boehringer). After washing the precipitates with lysis buffer (50 mM
Tris, 150 mM NaCl, 1 mM EDTA, and 1% Triton X-100), cyclin E precipi-
tates were resuspended in 2
 
 
 
 reaction buffer (40 mM Tris-HCl, pH 7.5,
and 15 mM MgCl
 
2
 
), 20 
 
 
 
M ATP, 20 
 
 
 
g histone H1, and 10 
 
 
 
Ci [
 
32
 
P]ATP
and incubated for 30 min at 38
 
 
 
C. Reaction products were separated by
SDS-PAGE and quantified with a phosphorimager (Storm
 
®
 
 840; Molecular
Dynamics). Cdk2 immunoprecipitates were resuspended in SDS-PAGE
sample buffer and were analyzed on 11% gels.
 
MCM4 RNA interference
 
A small interfering RNA (siRNA) duplex corresponding to nucleotides
1595–1615 of MCM4 mRNA was synthesized by Dharmacon Research
(Lafayette, CO). HeLa cells growing on coverslips were transfected every
24 h with Oligofectamine™ (Invitrogen) and a 100-nM final concentration
of MCM4 siRNA or firefly luciferase siRNA as a control. 48 h after the sec-
ond transfection, 10 
 
 
 
M BrdU was added to the medium for 15 min before
fixation and immunofluorescence analysis.
 
Online supplemental material
 
Analysis of chromatin-bound Mcm2 and Mcm6 is shown in Fig. S1, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200404092/DC1.
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